BANK OF AMERICA CORP /DE/ - ENDOLOGIX INC ownership

ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 104 filers reported holding ENDOLOGIX INC in Q4 2017. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of ENDOLOGIX INC
ValueSharesWeighting
Q4 2018$395,000
+265.7%
552,431
+880.9%
0.00%
Q3 2018$108,0000.0%56,318
+195.9%
0.00%
Q2 2018$108,000
-66.1%
19,031
-74.8%
0.00%
Q1 2018$319,000
+38.7%
75,438
+74.7%
0.00%
Q4 2017$230,000
+72.9%
43,184
+45.0%
0.00%
Q3 2017$133,000
-48.0%
29,775
-43.6%
0.00%
Q2 2017$256,000
-86.7%
52,778
-80.1%
0.00%
Q1 2017$1,922,000
+25.9%
265,523
-0.6%
0.00%
Q4 2016$1,527,000
-84.5%
267,035
-65.2%
0.00%
-100.0%
Q3 2016$9,826,000
-11.6%
767,655
-13.9%
0.00%
-33.3%
Q2 2016$11,115,000
+114.7%
891,996
+44.1%
0.00%
+200.0%
Q1 2016$5,176,000
-33.8%
619,027
-21.6%
0.00%
-50.0%
Q4 2015$7,816,000
+9.5%
789,493
+35.6%
0.00%0.0%
Q3 2015$7,140,000
-52.8%
582,429
-41.0%
0.00%
-60.0%
Q2 2015$15,132,000
-5.6%
986,428
+5.0%
0.01%0.0%
Q1 2015$16,029,000
+13.5%
939,018
+1.7%
0.01%0.0%
Q4 2014$14,118,000
+52.9%
923,363
+6.0%
0.01%
+66.7%
Q3 2014$9,231,000
-31.6%
870,834
-1.9%
0.00%
-25.0%
Q2 2014$13,500,000
+33.8%
887,610
+13.2%
0.00%0.0%
Q1 2014$10,090,000
+387.7%
783,915
+560.5%
0.00%
+300.0%
Q4 2013$2,069,000
+815.5%
118,686
+748.0%
0.00%
Q3 2013$226,000
-38.8%
13,996
-49.7%
0.00%
Q2 2013$369,00027,8150.00%
Other shareholders
ENDOLOGIX INC shareholders Q4 2017
NameSharesValueWeighting ↓
Tamarack Capital Management, LLC 4,000,000$68,280,0009.00%
Essex Woodlands Management, Inc. 1,257,468$26,843,0005.32%
First Light Asset Management, LLC 277,264$4,733,0002.42%
Lisanti Capital Growth, LLC 175,060$2,988,0001.70%
ArrowMark Colorado Holdings LLC 3,150,275$53,775,0001.39%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,349,351$40,103,0001.30%
Rail-Splitter Capital Management, LLC 186,076$3,176,0000.97%
WASHINGTON CAPITAL MANAGEMENT, INC 82,316$1,405,0000.81%
Perceptive Advisors 565,000$9,645,0000.75%
PALISADE CAPITAL MANAGEMENT, LP 1,629,329$27,813,0000.70%
View complete list of ENDOLOGIX INC shareholders